创意预览图

Biomedical schematic diagram for high-impact journal publication in Nature Reviews style, showing th

用户头像

GD442223348

2026.07.15
Ultra-detailed scientific illustration, flat vector style, showcasing the process of "Triparental Mating" for bacterial plasmid transfer. The image is divided into three clear stages from left to right. Stage 1: Three distinct bacterial cells in close proximity. 1 Donor E. coli: Contains a "mobilizable plasmid" with a visible "gene of interest" (like a fluorescent protein or antibiotic resistance marker) and an "oriT" site. 2 Helper E. coli: Contains a "conjugative plasmid" with visible "tra genes" (transfer genes) and pilus structures. 3 Recipient bacterium (e.g., a Rhizobium cell): Has a different cell wall shape, labeled, with no plasmid inside. Stage 2: The helper E. coli extends a "pilus" (a thin tube) to attach to the donor E. coli. The conjugative plasmid's tra genes mobilize the mobilizable plasmid. Show a clear arrow indicating the transfer of the mobilizable plasmid FROM the donor TO the helper cell. Stage 3: The helper E. coli, now carrying the mobilizable plasmid, extends a new pilus to attach to the recipient bacterium. Show a second arrow indicating the final transfer of the mobilizable plasmid INTO the recipient. The recipient bacterium now contains the plasmid. Use a distinct, consistent color scheme: Donor is Blue, Helper is Orange, Recipient is Green, Mobilizable Plasmid is Red, Conjugative Plasmid is Yellow. The background is clean white. All key elements have clear labels with leader lines. The style is educational, schematic, and extremely clear for a presentation slide.Ultra-detailed scientific illustration, flat vector style, showcasing the process of "Triparental Mating" for bacterial plasmid transfer. The image is divided into three clear stages from left to right. Stage 1: Three distinct bacterial cells in close proximity. 1 Donor E. coli: Contains a "mobilizable plasmid" with a visible "gene of interest" (like a fluorescent protein or antibiotic resistance marker) and an "oriT" site. 2 Helper E. coli: Contains a "conjugative plasmid" with visible "tra genes" (transfer genes) and pilus structures. 3 Recipient bacterium (e.g., a Rhizobium cell): Has a different cell wall shape, labeled, with no plasmid inside. Stage 2: The helper E. coli extends a "pilus" (a thin tube) to attach to the donor E. coli. The conjugative plasmid's tra genes mobilize the mobilizable plasmid. Show a clear arrow indicating the transfer of the mobilizable plasmid FROM the donor TO the helper cell. Stage 3: The helper E. coli, now carrying the mobilizable plasmid, extends a new pilus to attach to the recipient bacterium. Show a second arrow indicating the final transfer of the mobilizable plasmid INTO the recipient. The recipient bacterium now contains the plasmid. Use a distinct, consistent color scheme: Donor is Blue, Helper is Orange, Recipient is Green, Mobilizable Plasmid is Red, Conjugative Plasmid is Yellow. The background is clean white. All key elements have clear labels with leader lines. The style is educational, schematic, and extremely clear for a presentation slide.
将提供的五味子素抗特应性皮炎机制图全部转换为全中文版,保留原有的全部模块布局、实验流程、结构式和配色不变,所有英文文字翻译为规范中文: 1. 模块标题改为:1. 模型建立(体内)、2. 体内药效评价、3. 肥大细胞依赖性(遗传学验证)、4. 体外机制(肥大细胞层面)、5. 分子机制(信号通路) 2. 所有标注文字翻译为中文:C57BL/6野生型小鼠、局部涂抹MC903、MC903诱导AD模型小鼠、五味子素处理、低剂量25 mg/kg、中剂量50 mg/kg、高剂量100 mg/kg;AD样皮肤损伤:红斑、水肿、炎症浸润;行为学检测:搔抓、擦耳、自发行为;组织学分析:HE染色、甲苯胺蓝染色、类胰蛋白酶染色;炎症介质水平(ELISA法):TSLP、IgE、IL-4、IL-13、组胺、类胰蛋白酶、LTB4;结论:五味子素改善AD炎症表型;野生型小鼠(正常肥大细胞)、c-kit敲除小鼠(肥大细胞缺失)、MC903+五味子素、皮损改善、炎症介质减少;无明显改善、炎症介质无降低;结论:抗AD作用依赖肥大细胞;RBL-2H3肥大细胞、刺激:C48/80、五味子素、抑制脱颗粒、减少炎症介质释放:组胺、β-己糖胺酶、LTB4、IL-4、IL-13、类胰蛋白酶;C48/80刺激、PI3K、AKT、mTOR、P代表磷酸化、抑制线代表五味子素抑制、肥大细胞活化、炎症介质释放;底部大标题改为:五味子素通过靶向肥大细胞并抑制PI3K/AKT/mTOR信号通路缓解AD炎症和瘙痒 保持正确的五味子素结构式完全不变,整体风格保持专业学术,适合中文论文使用。将提供的五味子素抗特应性皮炎机制图全部转换为全中文版,保留原有的全部模块布局、实验流程、结构式和配色不变,所有英文文字翻译为规范中文:
1. 模块标题改为:1. 模型建立(体内)、2. 体内药效评价、3. 肥大细胞依赖性(遗传学验证)、4. 体外机制(肥大细胞层面)、5. 分子机制(信号通路)
2. 所有标注文字翻译为中文:C57BL/6野生型小鼠、局部涂抹MC903、MC903诱导AD模型小鼠、五味子素处理、低剂量25 mg/kg、中剂量50 mg/kg、高剂量100 mg/kg;AD样皮肤损伤:红斑、水肿、炎症浸润;行为学检测:搔抓、擦耳、自发行为;组织学分析:HE染色、甲苯胺蓝染色、类胰蛋白酶染色;炎症介质水平(ELISA法):TSLP、IgE、IL-4、IL-13、组胺、类胰蛋白酶、LTB4;结论:五味子素改善AD炎症表型;野生型小鼠(正常肥大细胞)、c-kit敲除小鼠(肥大细胞缺失)、MC903+五味子素、皮损改善、炎症介质减少;无明显改善、炎症介质无降低;结论:抗AD作用依赖肥大细胞;RBL-2H3肥大细胞、刺激:C48/80、五味子素、抑制脱颗粒、减少炎症介质释放:组胺、β-己糖胺酶、LTB4、IL-4、IL-13、类胰蛋白酶;C48/80刺激、PI3K、AKT、mTOR、P代表磷酸化、抑制线代表五味子素抑制、肥大细胞活化、炎症介质释放;底部大标题改为:五味子素通过靶向肥大细胞并抑制PI3K/AKT/mTOR信号通路缓解AD炎症和瘙痒
保持正确的五味子素结构式完全不变,整体风格保持专业学术,适合中文论文使用。
生成一张国际会议学术海报,主题关于外泌体作为天然化合物纳米载体的研究,遵循参考图片风格,蓝色系专业生物科技风格,三列式布局。 标题为 "Exosomes as Advanced Nanocarriers for Natural Compounds: From Biogenesis to Therapeutic Applications" 作者:Dan Yu,联系方式:×××××× 左列:1. Introduction:定义外泌体是30-150nm内体来源囊泡,细胞间通讯关键分子,临床理想标志物,总结外泌体生物发生和作为天然化合物递送载体潜力;左列下半部分:2. Exosome Biogenesis:源自晚期内体→多泡体,包含ESCRT依赖和ESCRT非依赖途径,多泡体与质膜融合释放,由Rab GTPases等调控,在此模块添加外泌体形成机制流程示意图 中列上:3. Exosome Composition:表面富含四跨膜蛋白CD9、CD63、CD81等,管腔包含蛋白质HSP70、HSP90、酶、RNA等,能量依赖内吞摄取;中列下:4. Why Exosomes? 优势:生物相容性好低毒性、免疫逃逸、靶向能力、多功能性可递送多种 payload 右列上:5. Delivery of Natural Compounds案例展示:姜黄素抗炎免疫调节内皮保护,EGCG诱导巨噬细胞表型转变抑制肿瘤,在此模块放置靶向设计或姜黄素作用机制示意图;右列下:6. Challenges & Future Perspectives:纯化标准化挑战、生产 scalability、装载效率、药代动力学稳定性,展望外泌体作为下一代给药系统 bridging传统医学和精准治疗。 整体英文表述,专业清晰,学术风格,蓝色配色,布局三列式从左到右背景/机制→成分/优势→药物递送案例/结论。生成一张国际会议学术海报,主题关于外泌体作为天然化合物纳米载体的研究,遵循参考图片风格,蓝色系专业生物科技风格,三列式布局。
标题为 "Exosomes as Advanced Nanocarriers for Natural Compounds: From Biogenesis to Therapeutic Applications"
作者:Dan Yu,联系方式:××××××
左列:1. Introduction:定义外泌体是30-150nm内体来源囊泡,细胞间通讯关键分子,临床理想标志物,总结外泌体生物发生和作为天然化合物递送载体潜力;左列下半部分:2. Exosome Biogenesis:源自晚期内体→多泡体,包含ESCRT依赖和ESCRT非依赖途径,多泡体与质膜融合释放,由Rab GTPases等调控,在此模块添加外泌体形成机制流程示意图
中列上:3. Exosome Composition:表面富含四跨膜蛋白CD9、CD63、CD81等,管腔包含蛋白质HSP70、HSP90、酶、RNA等,能量依赖内吞摄取;中列下:4. Why Exosomes? 优势:生物相容性好低毒性、免疫逃逸、靶向能力、多功能性可递送多种 payload
右列上:5. Delivery of Natural Compounds案例展示:姜黄素抗炎免疫调节内皮保护,EGCG诱导巨噬细胞表型转变抑制肿瘤,在此模块放置靶向设计或姜黄素作用机制示意图;右列下:6. Challenges & Future Perspectives:纯化标准化挑战、生产 scalability、装载效率、药代动力学稳定性,展望外泌体作为下一代给药系统 bridging传统医学和精准治疗。
整体英文表述,专业清晰,学术风格,蓝色配色,布局三列式从左到右背景/机制→成分/优势→药物递送案例/结论。